PL378406A1 - Sposób wytwarzania alkaloidów chinazolinowych - Google Patents

Sposób wytwarzania alkaloidów chinazolinowych

Info

Publication number
PL378406A1
PL378406A1 PL378406A PL37840604A PL378406A1 PL 378406 A1 PL378406 A1 PL 378406A1 PL 378406 A PL378406 A PL 378406A PL 37840604 A PL37840604 A PL 37840604A PL 378406 A1 PL378406 A1 PL 378406A1
Authority
PL
Poland
Prior art keywords
methods
quinazoline alkaloids
producing quinazoline
producing
alkaloids
Prior art date
Application number
PL378406A
Other languages
English (en)
Inventor
Joachim Moormann
Hans-Rainer Hoffmann
Rudolf Matusch
Original Assignee
Hf Arzneimittelforschung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32747532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL378406(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hf Arzneimittelforschung Gmbh filed Critical Hf Arzneimittelforschung Gmbh
Publication of PL378406A1 publication Critical patent/PL378406A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
PL378406A 2003-02-03 2004-01-22 Sposób wytwarzania alkaloidów chinazolinowych PL378406A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10304141A DE10304141B4 (de) 2003-02-03 2003-02-03 Verfahren zur Herstellung von Chinazolin-Alkaloiden

Publications (1)

Publication Number Publication Date
PL378406A1 true PL378406A1 (pl) 2006-04-03

Family

ID=32747532

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378406A PL378406A1 (pl) 2003-02-03 2004-01-22 Sposób wytwarzania alkaloidów chinazolinowych

Country Status (25)

Country Link
US (1) US7495096B2 (pl)
EP (1) EP1590351B1 (pl)
JP (1) JP2006516578A (pl)
KR (1) KR20050096165A (pl)
CN (1) CN100558727C (pl)
AR (1) AR042946A1 (pl)
AT (1) ATE407135T1 (pl)
AU (1) AU2004208873B2 (pl)
BR (1) BRPI0407012A (pl)
CA (1) CA2514945A1 (pl)
DE (2) DE10304141B4 (pl)
DK (1) DK1590351T3 (pl)
EA (1) EA009047B1 (pl)
ES (1) ES2314366T3 (pl)
MX (1) MXPA05008179A (pl)
MY (1) MY141734A (pl)
NO (1) NO20053689L (pl)
NZ (1) NZ541101A (pl)
PL (1) PL378406A1 (pl)
PT (1) PT1590351E (pl)
SI (1) SI1590351T1 (pl)
TW (1) TW200418811A (pl)
UA (1) UA81287C2 (pl)
WO (1) WO2004069836A1 (pl)
ZA (1) ZA200505160B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004048927A1 (de) * 2004-10-06 2006-04-20 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren
BR112020001698A2 (pt) 2017-08-03 2020-07-21 Galectin Sciences, Llc compostos para prevenção e tratamento de distúrbios médicos e usos dos mesmos
KR102728780B1 (ko) * 2021-11-30 2024-11-08 이화여자대학교 산학협력단 데옥시바시시논을 유효성분으로 포함하는 미백용 조성물 및 상기 데옥시바시시논 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
JP3180464B2 (ja) * 1991-08-30 2001-06-25 新日本理化株式会社 ジアセタール化合物の製造方法
DE19530606A1 (de) * 1995-08-21 1997-02-27 Basf Ag 1-(Pyridyl)-pyrazole
JP3958452B2 (ja) * 1997-10-31 2007-08-15 大日精化工業株式会社 新規化学発光試薬及びその製造方法
DE19906979B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906978B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906975B4 (de) 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz

Also Published As

Publication number Publication date
MY141734A (en) 2010-06-15
EA009047B1 (ru) 2007-10-26
AR042946A1 (es) 2005-07-06
JP2006516578A (ja) 2006-07-06
BRPI0407012A (pt) 2006-01-10
TW200418811A (en) 2004-10-01
ZA200505160B (en) 2007-01-31
US20060084669A1 (en) 2006-04-20
KR20050096165A (ko) 2005-10-05
CA2514945A1 (en) 2004-08-19
ES2314366T3 (es) 2009-03-16
DE10304141B4 (de) 2006-03-09
UA81287C2 (en) 2007-12-25
PT1590351E (pt) 2008-11-21
CN1745084A (zh) 2006-03-08
AU2004208873A1 (en) 2004-08-19
EP1590351A1 (de) 2005-11-02
WO2004069836A1 (de) 2004-08-19
NZ541101A (en) 2009-03-31
SI1590351T1 (sl) 2009-02-28
MXPA05008179A (es) 2006-02-17
DE502004007980D1 (de) 2008-10-16
NO20053689L (no) 2005-07-29
US7495096B2 (en) 2009-02-24
ATE407135T1 (de) 2008-09-15
CN100558727C (zh) 2009-11-11
EA200501135A1 (ru) 2006-02-24
DK1590351T3 (da) 2008-12-15
DE10304141A1 (de) 2004-08-26
HK1075898A1 (zh) 2005-12-30
EP1590351B1 (de) 2008-09-03
AU2004208873B2 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
GB0322409D0 (en) Quinazoline derivatives
IL174534A0 (en) Quinazoline derivatives
GB0321648D0 (en) Quinazoline derivatives
ZA200602264B (en) Quinazoline derivatives
IL174257A0 (en) Quinazoline derivatives
IL180247A0 (en) Method for producing 4-
IL182923A0 (en) Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
IL174390A0 (en) Quinazoline derivatives
GB0330002D0 (en) Quinazoline derivatives
IL175421A0 (en) Quinazoline derivatives
GB2387599B (en) Methods for producing antibodies
IL158016A0 (en) Method for preparing decorative elements
PL1697390T3 (pl) Sposób wytwarzania organoacylofosforynów
IL177233A0 (en) Method for producing polyisobutenylphenols
PL1831223T3 (pl) Sposób wytwarzania L-biopteryny
EP1612213A4 (en) PROCESS FOR PREPARING 2-DESOXY-2-FLUORURIDINE
SI1590351T1 (sl) Postopki za pripravo kinazolinskih alkaloidov
IL173238A0 (en) Methods for producing tetrabromobenzoate esters
GB0321621D0 (en) Quinazoline derivatives
GB0321620D0 (en) Quinazoline derivatives
IL175238A0 (en) Method for producing 4-pentafluoride-sulfanyl-benzoylguanidines
AM1402A2 (en) Hardtack preparing method
HU0300941D0 (en) Method for producing dialkyl-3-oxo-glutarates
SI1685097T1 (sl) Postopek za pripravo 4-pentafluorid-sulfanil-benzoilgvanidinov
GB0305460D0 (en) Methods for producing microstructures

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)